BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27438806)

  • 1. Global brain metabolic quantification with whole-head proton MRS at 3 T.
    Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
    NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.
    Davitz MS; Wu WE; Soher BJ; Babb JS; Kirov II; Huang J; Fatterpekar G; Gonen O
    Magn Reson Imaging; 2017 Jan; 35():15-19. PubMed ID: 27580518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
    Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
    Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children.
    Novak J; Wilson M; Macpherson L; Arvanitis TN; Davies NP; Peet AC
    Eur J Radiol; 2014 Feb; 83(2):e106-12. PubMed ID: 24331847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
    Amani V; Prince EW; Alimova I; Balakrishnan I; Birks D; Donson AM; Harris P; Levy JM; Handler M; Foreman NK; Venkataraman S; Vibhakar R
    BMC Cancer; 2016 Aug; 16():647. PubMed ID: 27538997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
    Broniscer A; Gajjar A; Bhargava R; Langston JW; Heideman R; Jones D; Kun LE; Taylor J
    Neurosurgery; 1997 Feb; 40(2):331-7; discussion 337-8. PubMed ID: 9007866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.
    Löbel U; Hwang S; Edwards A; Li Y; Li X; Broniscer A; Patay Z
    Neuroradiology; 2016 Oct; 58(10):1027-1034. PubMed ID: 27438806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
    Steffen-Smith EA; Venzon DJ; Bent RS; Hipp SJ; Warren KE
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):774-9. PubMed ID: 22445531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.
    Hipp SJ; Steffen-Smith E; Hammoud D; Shih JH; Bent R; Warren KE
    Neuro Oncol; 2011 Aug; 13(8):904-9. PubMed ID: 21757444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
    Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
    Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
    Warren KE; Poussaint TY; Vezina G; Hargrave D; Packer RJ; Goldman S; Wen PY; Pollack IF; Zurakowski D; Kun LE; Prados MD; Rutkowski S; Kieran MW
    Pediatr Blood Cancer; 2013 Sep; 60(9):1397-401. PubMed ID: 23625747
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.